DePuy ASR Hip Replacement Devices Class Action Lawsuit Attorneys
DePuy ASR Hip Replacement Devices Can Cause Serious Adverse Health Effects
On a yearly basis, over 265,000 people undergo hip replacement surgeries, with approximately twenty percent receiving what are known as “metal-on-metal” hip implantation devices. Such devices specifically contain a ball and socket, much like the hardware of a natural hip however, these are generally made from cobalt or chromium. For many years prior to the introduction of metal-on-metal implants into the public market, earlier hip implant devices were typically made from plastic or ceramic. However, over the past decade, orthopedic surgeons have preferred to use metal-on-metal implants given that they have been shown to be more resistant to normal wear and tear. One such popular replacement device, known as the DePuy ASR Resurfacing System, or “DePuy ASR,” is manufactured by DePuy Orthopaedics, Inc. (“DePuy”) and was released to the public during the summer of 2003. Since then however, the implant device has been the subject of a significant amount of media attention due to serious health effects and complications that have been reported by patients who received the DePuy ASR, such as:
- Persistent pain in the hips, back and groin
- Chronic pain during movement, including walking, sitting and standing
- Severe edema in the replacement area
- A loosening or dislocation of the device’s component parts
- A decrease in mobility and physical activity
- Toxic metal poisoning
- Post-implant revision surgeries
- Cancer and other serious diseases caused by toxic metal exposure
- Clicking or crunching noises emanating from the device
What Does the FDA Have to Say About the DePuy ASR?
Several credible studies have been released linking the DePuy ASR to all of the above-referenced health complications. As a result, DePuy voluntarily decided to recall its ASR metal-on-metal replacement device back in August of 2010. In addition, the FDA also sent DePuy a warning letter in December 2011, indicating that the company was improperly marking its various knee, hip, and other joint replacement implant devices. Moreover, the FDA further determined that DePuy’s hip replacement implant devices lacked appropriate quality control procedures, referencing the issues associated with the DePuy ASR as precedent. In other words, the FDA indicated that DePuy did not use proper scientific methods that would have revealed the numerous quality control issues associated with the DePuy ASR and several other similar devices manufactured by the company. Recently, the FDA has also acknowledged that those who received the DePuy ASR and other metal-on-metal joint replacement devices are at a much greater risk of being poisoned by the metals that make up these products.
What are Studies Revealing about the DePuy ASR?
Recent studies examining the risks associated with the DePuy ASR and other “metal-on-metal” hip implant devices reveal that they can cause serious and sometimes fatal health complications. According to DePuy, its recall of the DePuy ASR was primarily based upon a study published by the National Joint Registry of England and Wales, or the “NJREW.” According to the NJREW, one in eight people who received a metal-on-metal hip replacement device were forced to undergo corrective surgery to remove the defective product within five years of having initially received the hip replacement implant. This represents a failure rate of 12% to 13%, meaning that over 11,000 people out of the total 93,000 who received the DePuy ASR worldwide may have to undergo post-implant revision surgery. Additional studies suggest an even higher rate of failure of hip implantation devices similar to the DePuy ASR.
Lawsuits Are Mounting Against DePuy Orthopaedics, Inc.
In the past five years, approximately 6,000 people have sued DePuy due to serious complications that they have experienced after having hip replacement surgeries using the DePuy ASR. Given the volume of cases filed across the U.S. against DePuy, over 4,000 were consolidated in the United States District Court for the Northern District of Ohio. In the consolidated case entitled, “In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation, MDL No. 2197," plaintiffs generally allege (i) that DePuy defectively manufactured and/or designed its DePuy ASR and also failed to provide proper warnings regarding the risks associated with using the device. The first federal DePuy ASR hip replacement device recall trial is scheduled to begin on May 6, 2013, with the second set for July 8, 2013. Click here for more detailed information on the case.
Lawyers Are Available Now to Speak to You
It is important to speak with a lawyer who is capable of handling the numerous challenges associated with suing device manufacturers. Only seasoned attorneys can help victims of the DePuy ASR and other metal-on-metal hip and joint replacement implant devices receive the compensation that they deserve to cover the expenses that they have accrued as a direct result of their injuries. Moreover, experienced attorneys are also in the best position to apprise you of all of your legal options, the nature and scope of your rights and responsibilities, and also, can help you make informed decisions about your case – each and every step of the way.
Get a Free, Confidential DePuy ASR Legal Case Evaluation
Call Porter & Malouf, P.A. right now to find out more about how you can recover monetary damages for the injuries that have been caused by metal-on-metal hip replacement implant manufacturers. Our goals are to provide you with excellent representation and most importantly, to get your life back on track.